Integrated BioTherapeutics Overview

  • Founded
  • 2005

Founded
  • Status
  • Private

  • Employees
  • 43

Employees
  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1M

  • Investors
  • 9

Integrated BioTherapeutics General Information

Description

Developer of a research-based healthcare platform intended to help control infectious diseases. The company's platform specializes in toxin-based vaccines that protect against all ebolaviruses, a common cause of both hospital-acquired and community-acquired infections and bacterial sepsis, and also discover novel vaccines and therapeutics, enabling healthcare providers to treat emerging infectious diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 4 Research Court
  • Suite 300
  • Rockville, MD 20850
  • United States
+1 (877) 000-0000

Integrated BioTherapeutics Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Integrated BioTherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
18. Grant 12-May-2021 $1M 00.000 Completed
17. Grant 14-Mar-2019 00000 00.000 Completed
16. Grant 15-Feb-2017 00000 00.000 Completed
15. Grant 06-Jul-2020 00000 00.000 Completed
14. Grant 12-Jul-2019 00000 00.000 Completed Generating Revenue
13. Grant 12-Mar-2020 00000 00.000 Completed
12. Grant 20-Jun-2017 00.000 00.000 Completed Generating Revenue
11. Grant 01-Apr-2017 00000 00.000 Completed Generating Revenue
10. Grant 01-Aug-2014 $703K $3.98M Completed Generating Revenue
9. Debt - PPP 28-Apr-2020 $543K $3.98M Completed Generating Revenue
To view Integrated BioTherapeutics’s complete valuation and funding history, request access »

Integrated BioTherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a research-based healthcare platform intended to help control infectious diseases. The company's platform s
Drug Discovery
Rockville, MD
43 As of 2022
00.000
0000000000 00.000

000 00

idunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud ex
0000 000000000
Cambridge, MA
000 As of 0000
000.00
00000000 000.00

000000

s nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
0000 000000000
Durham, NC
00 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Integrated BioTherapeutics Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
VBI Vaccines Corporation Cambridge, MA 000 000.00 00000000 000.00
000000 Corporation Durham, NC 00 000.00 000000000 000.00
You’re viewing 2 of 2 competitors. Get the full list »

Integrated BioTherapeutics Patents

Integrated BioTherapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3069747-A1 Immunogenic composition comprising a fusion peptide derived from superantigen toxoids Pending 27-Jul-2017 000000000
EP-3658181-A1 Immunogenic composition comprising a fusion peptide derived from superantigen toxoids Pending 27-Jul-2017 000000000
EP-3658181-A4 Immunogenic composition comprising a fusion peptide derived from superantigen toxoids Pending 27-Jul-2017 0000000000
US-20200206335-A1 Immunogenic composition comprising a fusion peptide derived from superantigen toxoids Active 27-Jul-2017 0000000000
US-11260120-B2 Immunogenic composition comprising a fusion peptide derived from superantigen toxoids Active 27-Jul-2017 A61K39/085
To view Integrated BioTherapeutics’s complete patent history, request access »

Integrated BioTherapeutics Executive Team (4)

Name Title Board Seat Contact Info
Mohammad Aman Ph.D Chief Scientific Officer and President
Gary Nabors Chief Development Officer & Executive Vice President
Mahtab Hekmat Director of Finance & Administration
You’re viewing 3 of 4 executive team members. Get the full list »

Integrated BioTherapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Integrated BioTherapeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Novo Holdings Venture Capital Minority 000 0000 000000 0
CARB-X University 000 0000 000000 0
National Institute Of Allergy and Infectious Diseases Government 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
United States Army Government 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »